Literature DB >> 29024191

Non-specific pleuritis in patients with active malignancy.

Erik Vakil1,2, David Ost2, Macarena R Vial3, John Stewart4, Mona G Sarkiss5, Rodolfo C Morice2, Roberto F Casal2, Georgie A Eapen2, Horiana B Grosu2.   

Abstract

BACKGROUND AND
OBJECTIVE: Pleuroscopy is the test of choice for patients with suspected malignant pleural effusion and negative cytology. Biopsies negative for malignancy are frequently attributed to non-specific pleuritis, which poses a dilemma in patients with a known active malignancy, raising concern for a false-negative result. Our primary objective was to determine the outcomes of patients with active malignancy who had a non-malignant diagnosis on pleuroscopy.
METHODS: Retrospective review of all pleuroscopy cases from January 2005 to January 2015 at our institution was conducted. Biopsies were categorized by histopathology as malignant, eosinophilic or non-specific pleuritis. Malignant histopathology was considered a true positive. Eosinophilic or non-specific pleuritis was categorized as malignant, if malignancy was later identified during follow-up, or chemotherapy induced, possible radiation induced, other paramalignant, other benign or idiopathic.
RESULTS: Of the 199 pleuroscopy cases reviewed, 172 (86%) had a history of active malignancy. On histopathology, 73 (42%) had malignancy, 9 (5%) had eosinophilic pleuritis and 90 (52%) had non-specific pleuritis. Three patients with non-specific pleuritis were diagnosed with malignancy at follow-up. Pleuritis in 24 patients was chemotherapy induced, 27 were possibly radiation induced, 11 were other paramalignant and 3 were other benign. Idiopathic pleuritis was diagnosed in 31 patients. Patients were monitored for a mean of 23 ± 11 months.
CONCLUSION: The prevalence of malignant pleural disease was lower than expected for our patient population. Patients with no malignancy on histopathology were most likely to have non-specific pleuritis, a cause for which was identified in a majority of patients after clinical review.
© 2017 Asian Pacific Society of Respirology.

Entities:  

Keywords:  malignant pleural effusion; pleural endoscopy; pleuritis; pleuroscopy; pulmonary eosinophilia

Mesh:

Year:  2017        PMID: 29024191     DOI: 10.1111/resp.13187

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

1.  Clinical long-term outcome of non-specific pleuritis (NSP) after surgical or medical thoracoscopy.

Authors:  Georgia Karpathiou; Stavros Anevlavis; Olivier Tiffet; Francois Casteillo; Mousa Mobarki; Valentine Mismetti; Paschalis Ntolios; Andreas Koulelidis; Tiffany Trouillon; Nicolas Zadel; Sirine Hathroubi; Michel Peoc'h; Marios E Froudarakis
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

2.  The Intrapleural Bridge Connection is One of the Reasons for Unknown Localized Pleural Adhesion.

Authors:  Qihua Gu; Xinhao Deng; Zhao Li; Jing Wang; Chengping Hu; Shuhua Lei; Xiaoling Cai
Journal:  Int J Gen Med       Date:  2021-04-20

3.  Diagnosis of systemic lupus erythematosus by presence of Hargraves cells in eosinophilic pleural effusion: Case report.

Authors:  Alexia D'Andréa; Damien L Peillet; Christine Serratrice; Pierre-Augute Petignat; Virginie Prendki; Jean-Luc Reny; Jacques Serratrice
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

4.  IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: a case report.

Authors:  Takeshi Terashima; Eri Iwami; Takashi Shimada; Aoi Kuroda; Tatsu Matsuzaki; Takahiro Nakajima; Aya Sasaki; Keisuke Eguchi
Journal:  BMC Pulm Med       Date:  2020-04-25       Impact factor: 3.317

Review 5.  Inflammation of the Pleural Cavity: A Review on Pathogenesis, Diagnosis and Implications in Tumor Pathophysiology.

Authors:  Georgia Karpathiou; Michel Péoc'h; Anand Sundaralingam; Najib Rahman; Marios E Froudarakis
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.